PlainRecalls
FDA Drug Moderate Class II Terminated

Ciprofloxacin in Dextrose (5%) Injection, USP, 400 mg in 200 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-009-24

Reported: April 5, 2017 Initiated: March 10, 2017 #D-0613-2017

Product Description

Ciprofloxacin in Dextrose (5%) Injection, USP, 400 mg in 200 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-009-24

Reason for Recall

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Details

Recalling Firm
Claris Lifesciences Inc
Units Affected
18,360 units (765 cartons x 24 bags)
Distribution
Nationwide
Location
North Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Ciprofloxacin in Dextrose (5%) Injection, USP, 400 mg in 200 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-009-24. Recalled by Claris Lifesciences Inc. Units affected: 18,360 units (765 cartons x 24 bags).
Why was this product recalled?
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 5, 2017. Severity: Moderate. Recall number: D-0613-2017.